U.S. equities were slightly higher around midday ahead of a key report on consumer prices due tomorrow.
Eric Wall, Udi Wertheimer and Francisco Alarcon: Upgrading Bitcoin With Covenants
The founders of the popular Taproot Wizards JPEGs want to do more now to “make bitcoin magical again.”
Shayne Coplan: He Took Prediction Markets Mainstream
In so doing, Polymarket's founder demonstrated a real-world consumer use case for crypto, earning him a spot on CoinDesk's Most Influential 2024 list.
Microsoft shareholders vote against Bitcoin investment
Microsoft (MSFT) shareholders voted against adding Bitcoin to the company’s balance sheet on Tuesday.
Michael Saylor: The Architect of MicroStrategy’s Huge Bitcoin Bet
Most companies were leery of Saylor’s strategy when he started amassing bitcoin back in 2020. Some are no longer skeptical.
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
On Monday, the FDA approved Cumberland Pharmaceuticals Inc’s (NASDAQ:CPIX) supplemental New Drug Application (sNDA) for its Acetadote (N-acetylcysteine for injection) product. Acetadote is an intravenous (IV) formulation of N-acetylcysteine (NAC) indicated to prevent or lessen liver injury after ingestion of potentially toxic quantities of acetaminophen. Acetaminophen, a common over-the-counter pain reliever and fever reducer, is the leading cause of acute liver failure in the United States. Eac
CAF secures contracts for metro rolling stock in Latin America
CAF will deliver 13 metro trains to Metro de Medellín and six metro units to Metro Santiago.
Donald Trump: The Crypto President
His July speech at the Bitcoin Conference, in Nashville, was a turning point for crypto, promising an easier path for the industry heading into 2025.
ZachXBT: Master Sleuth of Crypto
Nobody catches blockchain criminals better.
Matthew Long: The UK’s Crypto Gatekeeper
Under Long, the Financial Conduct Authority has been slow to approve crypto firms operating in the UK. Impending new rules may change that, however.